Mark Spengler

Mark Spengler has a diverse work experience in the biotech industry. Mark started their career at G.A.G Biotech GmbH as an R&D-Scientist and CSO from 2000 to 2003. Mark then joined Chimera Biotec, where they held multiple roles including Product Manager from 2008 to 2010, Director Project Management from 2010 to 2019, and Director Global Business Development and Chief Executive Officer from 2014 to 2023. At BioAgilytix, Mark currently serves as the Senior Director Business Development, starting in September 2023.

Mark Spengler received their Diol. Biol. degree in Biology, Biotechnology, and Molecular Genetics from the University of Bremen from 1994 to 1999. Mark then pursued further education at TU Dortmund University, where they obtained their Dr. degree in Chemistry with a specialization in Biological and Chemical Microstructuring from 2003 to 2007.